Improving identification of patients at the greatest risk
Same Stage: Different Risk
myPlan Lung Cancer measures how fast a lung cancer tumor is growing. Fast growing tumors are more aggressive and correlated with higher risk. Tissue samples collected during surgery are used to determine the Molecular Prognostic Score (mPS) and calculate the patient’s five-year survival probability. Several studies have shown that myPlan Lung Cancer is an accurate and reproducible risk assessment based on the biological nature of the patient’s tumor (Ref: Bueno, Rakha, Eguchi).